SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-19-195719
Filing Date
2019-07-17
Accepted
2019-07-17 16:56:32
Documents
2
Group Members
JONATHAN A. FLINTPOLARIS VENTURE MANAGEMENT CO. IV, L.L.C.POLARIS VENTURE MANAGEMENT CO. V, L.L.C.POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND IV, L.P.POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.POLARIS VENTURE PARTNERS FOUNDERS FUND V, L.P.POLARI

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d756830dsc13da.htm SC 13D/A 200583
2 EX-99.A d756830dex99a.htm EX-99.A 14346
  Complete submission text file 0001193125-19-195719.txt   217048
Mailing Address ONE MARINA PARK DRIVE 10TH FLOOR BOSTON MA 02210
Business Address ONE MARINA PARK DRIVE 10TH FLOOR BOSTON MA 02210 781-290-0770
Polaris Venture Partners V, L.P. (Filed by) CIK: 0001439590 (see all company filings)

IRS No.: 204234825 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Subject) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88056 | Film No.: 19959588
SIC: 2834 Pharmaceutical Preparations